MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Diagnostic Spectrum in a Cohort of Atypical Atypical Parkinsonism

    P. Katragadda, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

    Objective: To retrospectively look at atypical Parkinsonism mimics in our cohort and reappraise the clinical features of these subset of patients Background: Atypical parkinsonism syndromes…
  • 2024 International Congress

    18F-Florzolotau PET uncovers the Co-pathological Heterogeneity of Tau Protein in Dementia with Lewy Bodies

    G. Tang, XY. Li, FT. Liu, J. Wang (Shanghai, China)

    Objective: We attempted to reveal the topographical deposition patterns of tau proteins in the living brains of patients with DLB in vivo by virtue of…
  • 2024 International Congress

    Sex Differences for Regional Lewy Body Pathology in Pathologically-Defined Lewy Body Dementia

    E. Bayram, D. Coughlin, S. Koga, I. Litvan, D. Dickson (La Jolla, USA)

    Objective: To investigate sex differences for regional Lewy body (LB) pathology burden, and regional LB pathology association with clinical diagnosis across people with a high…
  • 2024 International Congress

    Identification of Novel Blood Biomarkers among Data-Driven Parkinson’s Disease Clusters in Asian Populations

    X. Dneg, L. Tan, E. Tan, A. Ng, J. Tan (Singapore, Singapore)

    Objective: The aim of this study is to explore the correlation between emerging serum biomarkers and subtypes of Parkinson's disease (PD). Background: PD is a…
  • 2024 International Congress

    Early Syndromes and Clinicopathologic Progression in Progressive Supranuclear Palsy

    D. Ono, H. Sekiya, N. Ghayal, A. Maier, S. Roemer, D. Dickson (Jacksonville, USA)

    Objective: We aimed to characterize early clinical features of progressive supranuclear palsy (PSP) that might correlate with clinical course and neuropathologic findings. Background: Progressive supranuclear…
  • 2024 International Congress

    Familial Multiple System Atrophy-Mimics: Importance of Comprehensive Evaluation

    CH. Jeong, HJ. Kim (Seoul, Republic of Korea)

    Objective: We present two patients initially diagnosed as familial MSA until one of the patients was proven to be metachromatic leukodystrophy (MLD). Background: Multiple system…
  • 2024 International Congress

    Ethnic Diversity and Symptomatology in Parkinson’s Disease with a Focus on Falls and Vertical Gaze Palsy

    D. Trivedi, C. Edwards, KC. Dey, E. Camboe, T. Haque, A. Joseph, J. Kahan, D. Gallagher, T. Boyle, C. Budu, B. Huxford, C. Simonet, S. Ganesh, A. Lee, C. Marshall, A. Noyce, A. Zirra (London, United Kingdom)

    Objective: The objective of this study was to explore atypical features in the clinical phenotype of people with Parkinson’s disease (PwP) enrolled in the East…
  • 2024 International Congress

    New α-Synuclein Strain Biomarker in Parkinson’s Disease and Related Dementia

    K. Gadhave, R. Chen, V. Dawson, T. Dawson, L. Rosenthal, X. Mao ()

    Objective: Biomarker development for Parkinson’s disease and related dementia. Background: α-Synuclein (α-syn) strains can serve as discriminators of Parkinson's disease (PD) from other α-synucleinopathies. However,…
  • 2024 International Congress

    Impact of Prior Head Trauma on Parkinson’s Disease Experience

    S. Vallamkonda, A. Hohler (Boston, USA)

    Objective: We aim to characterize the impact of prior head trauma on Parkinson’s disease (PD) related outcomes. Background: Previous head trauma is correlated with detrimental…
  • 2024 International Congress

    Unveiling the Link: Insulin’s Novel Role in Modulating α-Synuclein Accumulation in Parkinson’s Disease

    Y. Wu (München, Germany)

    Objective: This study marks the inaugural attempt to investigate the direct effects of insulin on pathological α-synuclein accumulation induced by the addition of α-synuclein preformed…
  • « Previous Page
  • 1
  • …
  • 103
  • 104
  • 105
  • 106
  • 107
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley